Literature DB >> 12394384

The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease.

Anthony Otley1, Claire Smith, David Nicholas, Marla Munk, Julie Avolio, Philip M Sherman, Anne M Griffiths.   

Abstract

UNLABELLED: BACKGROUND AND AIMS IMPACT: is a disease-specific health-related quality-of-life questionnaire developed for use in pediatric inflammatory bowel disease through a process of patient interviews and analysis of patient responses to an item-reduction questionnaire. This study sought to assess the feasibility, reliability, and validity of the instrument.
METHODS: The readability statistics and number of unanswered questions were assessed among 147 patients (97 CD, 50 UC) with mean age 14.4 +/- 2.2 years (range 9.2-18.0 years) using the self-administered questionnaire. Internal consistency was assessed with Cronbach's alpha and test-retest reliability using intraclass correlation coefficient (ICC). Construct validity was based on a priori hypotheses. Mean total scores were compared by ANOVA among patients grouped according to disease activity and disease severity within the past year.
RESULTS: The readability statistic showed a Flesch-Kincaid Grade level of 4.5. Only 0.68% of questions were left blank. Reliability was excellent with Cronbach's alpha = 0.96, and an ICC of 0.90 in patients with stable disease over a two-week period (n = 32). The mean total IMPACT score for patients with quiescent disease (180 +/- 32) was significantly higher (better QOL) than for those with active disease (146 +/- 31 for mild, 133 +/- 34 for moderate/severe) (P < 0.005).
CONCLUSIONS: The IMPACT questionnaire is a valid and reliable reflection of health-related quality of life of older children and adolescents with both ulcerative colitis and Crohn's disease.

Entities:  

Mesh:

Year:  2002        PMID: 12394384     DOI: 10.1097/00005176-200210000-00018

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  66 in total

1.  A randomized controlled trial of growth hormone in active pediatric Crohn disease.

Authors:  Lee A Denson; Mi-Ok Kim; Ramona Bezold; Rebecca Carey; Bankole Osuntokun; Cade Nylund; Tara Willson; Erin Bonkowski; Dandan Li; Edgar Ballard; Margaret Collins; M Susan Moyer; David J Klein
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-08       Impact factor: 2.839

2.  Impact of a Camp upon Disease-Specific Knowledge and Quality of Life in Children and Adolescents with Inflammatory Bowel Disease.

Authors:  Robert N Lopez; Andrew McCombie; Richard B Gearry; Andrew S Day
Journal:  Inflamm Intest Dis       Date:  2020-02-26

3.  Changes in inflammation and QoL after a single dose of infliximab during ongoing IBD treatment.

Authors:  Mark D DeBoer; Barrett H Barnes; Nicholas A Stygles; James L Sutphen; Stephen M Borowitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

4.  Behavioral Functioning and Treatment Adherence in Pediatric Inflammatory Bowel Disease: Review and Recommendations for Practice.

Authors:  Kevin A Hommel; Lee A Denson; Wallace V Crandall; Laura M Mackner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-11-01

5.  Family functioning and health-related quality of life in adolescents with pediatric inflammatory bowel disease.

Authors:  Michele Herzer; Lee A Denson; Robert N Baldassano; Kevin A Hommel
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 2.566

6.  Variation in the readability of items within surveys.

Authors:  José L Calderón; Leo S Morales; Honghu Liu; Ron D Hays
Journal:  Am J Med Qual       Date:  2006 Jan-Feb       Impact factor: 1.852

7.  Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens
Journal:  J Pediatr Psychol       Date:  2018-10-01

8.  Changes in health-related quality of life over a 1-year follow-up period in children with inflammatory bowel disease.

Authors:  Helene Werner; Markus A Landolt; Patrick Buehr; Rebekka Koller; Andreas Nydegger; Johannes Spalinger; Klaas Heyland; Susanne Schibli; Christian P Braegger
Journal:  Qual Life Res       Date:  2017-02-14       Impact factor: 4.147

9.  Childhood inflammatory bowel disease: parental concerns and expectations.

Authors:  A-S Day; K-E Whitten; T-D Bohane
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

Review 10.  Special issues in pediatric inflammatory bowel disease.

Authors:  Marla Dubinsky
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.